Seaport Therapeutics Inc. Common Stock
SPTX | NASDAQ
$19.95
+$0.35 (+1.79%)
Nov 2, 2026, 12:09 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Revenue | n/a | n/a |
Cost of Revenue | 351K | n/a |
Gross Profit | -351K | n/a |
Operating Income | -93.35M | -27.54M |
Interest Income | 5.39M | 2.13M |
Pretax Income | -87.47M | -24.89M |
Net Income | -88.01M | -25.41M |
Selling & General & Admin | 46.95M | 6.11M |
Research & Development | 46.05M | 21.43M |
Other Expenses | n/a | n/a |
Operating Expenses | 93M | 27.54M |
Interest Expense | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 93.35M | 27.54M |
Income Tax Expense | 534K | 519K |
Shares Outstanding (Basic) | 53.53M | 53.03M |
Shares Outstanding (Diluted) | 53.53M | 53.03M |
EPS (Basic) | -1.65 | -0.48 |
EPS (Diluted) | -1.65 | -0.48 |
EBITDA | -92.64M | -27.19M |
EBIT | -93.35M | -27.54M |
Depreciation & Amortization | 708K | 357K |
Add to Watchlist
Select watchlists to add or remove SPTX